Liquid biopsy at the frontier in renal cell carcinoma: recent analysis of techniques and clinical application

M Li, L Li, J Zheng, Z Li, S Li, K Wang, X Chen - Molecular Cancer, 2023 - Springer
Renal cell carcinoma (RCC) is a major pathological type of kidney cancer and is one of the
most common malignancies worldwide. The unremarkable symptoms of early stages …

Tumor mutational burden for predicting prognosis and therapy outcome of hepatocellular carcinoma

D Gabbia, S De Martin - International journal of molecular sciences, 2023 - mdpi.com
Hepatocellular carcinoma (HCC), the primary hepatic malignancy, represents the second-
highest cause of cancer-related death worldwide. Many efforts have been devoted to finding …

Biomarkers and prognostic factors of PD-1/PD-L1 inhibitor-based therapy in patients with advanced hepatocellular carcinoma

N Zhang, X Yang, M Piao, Z Xun, Y Wang, C Ning… - Biomarker …, 2024 - Springer
Systemic therapies using programmed death-1 (PD-1) and programmed death ligand 1 (PD-
L1) inhibitors have demonstrated commendable efficacy in some patients with advanced …

Predictive biomarkers for immune-checkpoint inhibitor treatment response in patients with hepatocellular carcinoma

JH Ji, SY Ha, D Lee, K Sankar, EK Koltsova… - International Journal of …, 2023 - mdpi.com
Hepatocellular carcinoma (HCC) has one of the highest mortality rates among solid cancers.
Late diagnosis and a lack of efficacious treatment options contribute to the dismal prognosis …

The Use of ctDNA in the Diagnosis and Monitoring of Hepatocellular Carcinoma—Literature Review

A Kopystecka, R Patryn, M Leśniewska… - International Journal of …, 2023 - mdpi.com
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and is one of the
leading causes of cancer-related deaths worldwide. Despite advances in medicine, it is still …

Prospect of immunotherapy alone in patients with advanced NSCLC with high btmb: a review and a meta-analysis

F Zhao, X Qiu, Q Yang, S Gao, F Yang… - Holistic Integrative …, 2023 - Springer
Lung cancer is the most prevalent cancer in the world, and the main treatment for advanced
non-small cell lung cancer is immunotherapy combined with chemotherapy. In recent years …

Liquid biopsy in hepatocellular carcinoma: Utility of circulating cell-free DNA profiling and cytokine levels in hepatocellular carcinoma management

E Vargas-Accarino - 2023 - ddd.uab.cat
El carcinoma hepatocel· lular és la segona causa de mort relacionada amb el càncer i la
seva incidència està augmentant a tot el món. Els tractaments amb intenció curativa només …

Liquid biopsy in hepatocellular carcinoma: Utility of circulating cell-free DNA profiling and cytokine levels in hepatocellular carcinoma management

E Vargas-Accarino - 2023 - tdx.cat
El carcinoma hepatocelular es la segunda causa de muerte relacionada con el cáncer y su
incidencia está aumentando en todo el mundo. Los tratamientos con intención curativa solo …